13.3 |
39.9 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
8.0 |
40.0 |
GO:1903282 |
negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
5.5 |
22.0 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
5.4 |
21.6 |
GO:0006208 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
5.1 |
15.4 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
4.9 |
14.8 |
GO:2000854 |
positive regulation of corticosterone secretion(GO:2000854) |
4.7 |
14.2 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
3.8 |
11.3 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
3.4 |
10.2 |
GO:0007412 |
axon target recognition(GO:0007412) |
3.0 |
15.0 |
GO:0051941 |
regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
2.7 |
10.8 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) |
2.7 |
8.1 |
GO:0046125 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
2.6 |
13.2 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
2.6 |
7.8 |
GO:1902997 |
regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
2.6 |
15.3 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
2.5 |
7.6 |
GO:1903487 |
regulation of lactation(GO:1903487) |
2.5 |
35.3 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
2.4 |
7.3 |
GO:2000532 |
renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
2.4 |
7.1 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
2.3 |
6.9 |
GO:0002881 |
negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
2.3 |
11.5 |
GO:0048478 |
replication fork protection(GO:0048478) |
2.1 |
8.5 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
2.1 |
10.6 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
2.1 |
6.4 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
2.1 |
10.6 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
2.1 |
6.3 |
GO:2001302 |
cellular response to interleukin-13(GO:0035963) lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
2.1 |
25.1 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
2.1 |
10.4 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
2.1 |
8.2 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
2.0 |
6.0 |
GO:0071048 |
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
2.0 |
10.0 |
GO:0033078 |
extrathymic T cell differentiation(GO:0033078) |
2.0 |
13.7 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
1.8 |
1.8 |
GO:2000537 |
regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
1.8 |
9.1 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
1.8 |
14.4 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.7 |
5.2 |
GO:0030187 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
1.7 |
6.9 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
1.7 |
13.8 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
1.7 |
5.1 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
1.7 |
18.7 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.7 |
13.4 |
GO:0015705 |
iodide transport(GO:0015705) |
1.6 |
6.6 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
1.6 |
4.9 |
GO:0071529 |
cementum mineralization(GO:0071529) |
1.6 |
8.1 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
1.6 |
4.8 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
1.6 |
6.4 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.6 |
4.8 |
GO:0015888 |
thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
1.6 |
4.8 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
1.6 |
4.7 |
GO:0046440 |
L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
1.5 |
16.7 |
GO:0042904 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.5 |
12.0 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
1.4 |
13.0 |
GO:0014744 |
positive regulation of muscle adaptation(GO:0014744) |
1.4 |
11.5 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
1.4 |
10.0 |
GO:0010269 |
response to selenium ion(GO:0010269) |
1.4 |
18.4 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
1.3 |
8.0 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.3 |
7.8 |
GO:0052565 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
1.3 |
22.9 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
1.2 |
6.2 |
GO:0019722 |
calcium-mediated signaling(GO:0019722) |
1.2 |
3.7 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
1.2 |
4.9 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
1.2 |
6.0 |
GO:0072233 |
thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
1.1 |
4.5 |
GO:0000023 |
maltose metabolic process(GO:0000023) |
1.1 |
4.5 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
1.1 |
18.9 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
1.1 |
3.3 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.1 |
3.2 |
GO:0010902 |
positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
1.1 |
3.2 |
GO:0038178 |
complement component C5a signaling pathway(GO:0038178) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
1.1 |
5.3 |
GO:0070370 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
1.1 |
6.3 |
GO:0018343 |
protein farnesylation(GO:0018343) |
1.0 |
7.3 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
1.0 |
7.3 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
1.0 |
8.2 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
1.0 |
17.4 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
1.0 |
5.1 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
1.0 |
7.1 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) protein localization to juxtaparanode region of axon(GO:0071205) |
1.0 |
8.0 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
1.0 |
14.1 |
GO:0032196 |
transposition(GO:0032196) |
1.0 |
1.9 |
GO:0048867 |
stem cell fate determination(GO:0048867) |
1.0 |
4.8 |
GO:0032661 |
regulation of interleukin-18 production(GO:0032661) |
1.0 |
1.9 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
0.9 |
16.1 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
0.9 |
7.6 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
0.9 |
4.7 |
GO:0033504 |
floor plate development(GO:0033504) |
0.9 |
8.4 |
GO:0086024 |
adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.9 |
10.2 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.9 |
12.6 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
0.9 |
5.3 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
0.9 |
4.3 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.9 |
3.4 |
GO:0034201 |
response to oleic acid(GO:0034201) |
0.9 |
12.8 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
0.8 |
12.7 |
GO:0021513 |
spinal cord dorsal/ventral patterning(GO:0021513) |
0.8 |
1.7 |
GO:0042746 |
regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.8 |
10.1 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.8 |
9.2 |
GO:2000582 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.8 |
2.5 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
0.8 |
8.2 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.8 |
20.4 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
0.8 |
0.8 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
0.8 |
4.7 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
0.8 |
8.5 |
GO:0034372 |
triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.8 |
9.2 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
0.8 |
9.8 |
GO:0045919 |
positive regulation of cytolysis(GO:0045919) |
0.7 |
3.0 |
GO:2000342 |
negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.7 |
2.2 |
GO:0002727 |
natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.7 |
5.2 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
0.7 |
5.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
0.7 |
17.7 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
0.7 |
3.7 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
0.7 |
20.5 |
GO:0034204 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.7 |
4.4 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
0.7 |
7.3 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) action potential propagation(GO:0098870) |
0.7 |
12.4 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
0.7 |
22.7 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.7 |
2.8 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
0.7 |
4.1 |
GO:1903960 |
regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) plasma membrane long-chain fatty acid transport(GO:0015911) negative regulation of anion transmembrane transport(GO:1903960) |
0.7 |
2.7 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
0.7 |
2.7 |
GO:0045829 |
negative regulation of isotype switching(GO:0045829) |
0.7 |
9.6 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
0.7 |
3.4 |
GO:0010513 |
positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.7 |
5.3 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
0.6 |
5.7 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.6 |
5.7 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
0.6 |
31.7 |
GO:0050911 |
detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.6 |
1.9 |
GO:0044537 |
regulation of circulating fibrinogen levels(GO:0044537) |
0.6 |
1.9 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
0.6 |
3.6 |
GO:0002920 |
regulation of humoral immune response(GO:0002920) regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.6 |
3.0 |
GO:0050955 |
thermoception(GO:0050955) |
0.6 |
2.9 |
GO:0007129 |
synapsis(GO:0007129) |
0.6 |
2.3 |
GO:0060133 |
somatotropin secreting cell development(GO:0060133) |
0.6 |
4.6 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
0.6 |
2.8 |
GO:0015688 |
response to mycotoxin(GO:0010046) iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.6 |
7.2 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.6 |
14.3 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
0.5 |
10.4 |
GO:0006743 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.5 |
2.7 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
0.5 |
4.9 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
0.5 |
2.2 |
GO:0007525 |
somatic muscle development(GO:0007525) |
0.5 |
10.8 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 |
2.1 |
GO:0032218 |
riboflavin transport(GO:0032218) |
0.5 |
4.8 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
0.5 |
5.7 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
0.5 |
5.1 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.5 |
5.5 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
0.5 |
14.4 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
0.5 |
15.5 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.5 |
1.4 |
GO:0070781 |
arginine biosynthetic process via ornithine(GO:0042450) response to biotin(GO:0070781) |
0.5 |
1.4 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.5 |
3.3 |
GO:0046618 |
drug export(GO:0046618) |
0.5 |
7.5 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
0.5 |
7.8 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
0.5 |
2.8 |
GO:0060154 |
cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.5 |
5.0 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
0.4 |
1.8 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
0.4 |
1.7 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
0.4 |
1.7 |
GO:0043324 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) regulation of melanosome transport(GO:1902908) |
0.4 |
11.5 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
0.4 |
4.2 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
0.4 |
5.0 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.4 |
3.8 |
GO:0006477 |
protein sulfation(GO:0006477) |
0.4 |
6.2 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
0.4 |
2.5 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
0.4 |
6.1 |
GO:0045926 |
negative regulation of cell growth(GO:0030308) negative regulation of growth(GO:0045926) |
0.4 |
4.5 |
GO:0048007 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 |
2.4 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
0.4 |
1.2 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.4 |
2.4 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
0.4 |
10.3 |
GO:0097503 |
sialylation(GO:0097503) |
0.4 |
1.6 |
GO:0060748 |
tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.4 |
4.6 |
GO:0042354 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.4 |
0.8 |
GO:1903059 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.4 |
4.2 |
GO:0045046 |
protein import into peroxisome membrane(GO:0045046) |
0.4 |
1.1 |
GO:0019605 |
benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.4 |
4.9 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
0.4 |
58.4 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 |
7.2 |
GO:0051480 |
regulation of cytosolic calcium ion concentration(GO:0051480) |
0.4 |
3.5 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
0.3 |
3.6 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 |
1.3 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
0.3 |
4.1 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
0.3 |
0.9 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.3 |
8.7 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
0.3 |
6.5 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
0.3 |
11.8 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
0.3 |
8.9 |
GO:0050832 |
defense response to fungus(GO:0050832) |
0.3 |
0.9 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 |
1.8 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
0.3 |
3.5 |
GO:0034505 |
tooth mineralization(GO:0034505) |
0.3 |
11.0 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
0.3 |
2.2 |
GO:0019375 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.3 |
11.7 |
GO:0019228 |
neuronal action potential(GO:0019228) |
0.3 |
5.3 |
GO:0051923 |
sulfation(GO:0051923) |
0.3 |
1.6 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.3 |
2.2 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.3 |
1.1 |
GO:0097283 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.3 |
33.4 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
0.3 |
7.1 |
GO:0030488 |
tRNA methylation(GO:0030488) |
0.3 |
7.1 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.2 |
12.4 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
0.2 |
18.1 |
GO:0050771 |
negative regulation of axonogenesis(GO:0050771) |
0.2 |
2.1 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
0.2 |
2.8 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
0.2 |
2.8 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
0.2 |
7.4 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.2 |
4.6 |
GO:0006833 |
water transport(GO:0006833) |
0.2 |
8.9 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 |
0.6 |
GO:0034197 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.2 |
6.2 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
0.2 |
7.3 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
0.2 |
11.3 |
GO:0060997 |
dendritic spine morphogenesis(GO:0060997) |
0.2 |
1.0 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.2 |
3.9 |
GO:0030889 |
negative regulation of B cell proliferation(GO:0030889) |
0.2 |
7.3 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
0.2 |
2.8 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
0.2 |
1.8 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
0.2 |
6.7 |
GO:0010107 |
potassium ion import(GO:0010107) |
0.2 |
6.0 |
GO:0042795 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 |
1.4 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
0.2 |
10.1 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
0.2 |
4.5 |
GO:0010762 |
regulation of fibroblast migration(GO:0010762) |
0.2 |
3.8 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
0.2 |
0.9 |
GO:0015842 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.2 |
3.6 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
0.2 |
4.1 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
0.2 |
1.7 |
GO:0048016 |
inositol phosphate-mediated signaling(GO:0048016) |
0.2 |
6.8 |
GO:0016266 |
O-glycan processing(GO:0016266) |
0.2 |
23.2 |
GO:0046718 |
viral entry into host cell(GO:0046718) |
0.2 |
2.8 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 |
1.8 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 |
4.1 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 |
3.7 |
GO:0035338 |
long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.2 |
2.0 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
0.2 |
5.6 |
GO:0007339 |
binding of sperm to zona pellucida(GO:0007339) |
0.2 |
5.2 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
0.2 |
2.3 |
GO:0050974 |
detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.2 |
5.1 |
GO:0060512 |
prostate gland morphogenesis(GO:0060512) |
0.1 |
3.0 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
0.1 |
2.5 |
GO:0006465 |
signal peptide processing(GO:0006465) |
0.1 |
1.5 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
0.1 |
6.0 |
GO:0070206 |
protein trimerization(GO:0070206) |
0.1 |
2.8 |
GO:1903861 |
positive regulation of dendrite extension(GO:1903861) |
0.1 |
8.2 |
GO:0006305 |
DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 |
5.6 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 |
4.0 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
0.1 |
1.7 |
GO:0036344 |
platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.1 |
5.4 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
0.1 |
3.9 |
GO:0050776 |
regulation of immune response(GO:0050776) |
0.1 |
2.2 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 |
4.4 |
GO:0045843 |
negative regulation of striated muscle tissue development(GO:0045843) |
0.1 |
1.3 |
GO:0007350 |
blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 |
2.4 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
0.1 |
5.5 |
GO:0042073 |
intraciliary transport(GO:0042073) |
0.1 |
1.0 |
GO:0070986 |
left/right axis specification(GO:0070986) |
0.1 |
10.1 |
GO:0070268 |
cornification(GO:0070268) |
0.1 |
7.5 |
GO:0030101 |
natural killer cell activation(GO:0030101) |
0.1 |
0.1 |
GO:0035992 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 |
5.1 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
0.1 |
6.3 |
GO:0002576 |
platelet degranulation(GO:0002576) |
0.1 |
0.1 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 |
2.6 |
GO:0033572 |
transferrin transport(GO:0033572) |
0.1 |
2.2 |
GO:0014002 |
astrocyte development(GO:0014002) |
0.1 |
1.7 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
0.1 |
1.7 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
0.1 |
1.4 |
GO:0060828 |
regulation of canonical Wnt signaling pathway(GO:0060828) |
0.1 |
5.5 |
GO:0044782 |
cilium organization(GO:0044782) |
0.1 |
1.4 |
GO:0032418 |
lysosome localization(GO:0032418) |
0.1 |
0.8 |
GO:0050869 |
negative regulation of B cell activation(GO:0050869) |
0.1 |
2.8 |
GO:0019835 |
cytolysis(GO:0019835) |
0.1 |
0.8 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
0.1 |
5.1 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
0.1 |
0.5 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) Sertoli cell proliferation(GO:0060011) |
0.1 |
0.6 |
GO:0060333 |
interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 |
0.2 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
0.1 |
2.6 |
GO:0060271 |
cilium morphogenesis(GO:0060271) |
0.1 |
14.8 |
GO:0045666 |
positive regulation of neuron differentiation(GO:0045666) |
0.1 |
8.9 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
0.1 |
0.8 |
GO:0045087 |
innate immune response(GO:0045087) |
0.1 |
8.6 |
GO:1902807 |
negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 |
2.1 |
GO:0007585 |
respiratory gaseous exchange(GO:0007585) |
0.1 |
6.1 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
0.1 |
1.3 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 |
1.2 |
GO:0044804 |
nucleophagy(GO:0044804) |
0.1 |
1.4 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.1 |
3.4 |
GO:0016079 |
synaptic vesicle exocytosis(GO:0016079) |
0.1 |
1.1 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 |
3.4 |
GO:0018410 |
C-terminal protein amino acid modification(GO:0018410) |
0.1 |
0.7 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
0.1 |
7.6 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
0.1 |
2.4 |
GO:0007595 |
lactation(GO:0007595) |
0.1 |
0.7 |
GO:0030193 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 |
3.9 |
GO:0070301 |
cellular response to hydrogen peroxide(GO:0070301) |
0.1 |
0.9 |
GO:0003334 |
keratinocyte development(GO:0003334) |
0.0 |
2.9 |
GO:0045576 |
mast cell activation(GO:0045576) |
0.0 |
1.2 |
GO:0015695 |
organic cation transport(GO:0015695) |
0.0 |
2.1 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
0.0 |
3.2 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
0.0 |
2.7 |
GO:0010951 |
negative regulation of endopeptidase activity(GO:0010951) |
0.0 |
0.7 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
0.0 |
7.2 |
GO:0051056 |
regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 |
1.8 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) |
0.0 |
1.8 |
GO:0021762 |
substantia nigra development(GO:0021762) |
0.0 |
0.4 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 |
3.7 |
GO:0007265 |
Ras protein signal transduction(GO:0007265) |
0.0 |
1.8 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
0.0 |
0.4 |
GO:1902895 |
positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 |
0.9 |
GO:0043149 |
contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 |
4.6 |
GO:0007411 |
axon guidance(GO:0007411) |
0.0 |
3.2 |
GO:0006661 |
phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 |
1.0 |
GO:0008217 |
regulation of blood pressure(GO:0008217) |
0.0 |
0.1 |
GO:0071386 |
cellular response to corticosterone stimulus(GO:0071386) |
0.0 |
1.7 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 |
1.3 |
GO:0035264 |
multicellular organism growth(GO:0035264) |
0.0 |
0.4 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
0.0 |
0.4 |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 |
0.2 |
GO:0042730 |
fibrinolysis(GO:0042730) |
0.0 |
0.2 |
GO:0050890 |
cognition(GO:0050890) |